From the browser to the back end, the ‘boring’ choice is exciting again. We look at three trends converging to bring SQL back ...
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable ...
The committee, formed by InMode's board, evaluated multiple proposals for a potential transaction with help from outside financial and legal advisers. After reviewing the final bids, it concluded that ...
In a report released today, Matt Miksic from Barclays maintained a Buy rating on InMode, with a price target of $21.00. According to TipRanks, Miksic is a 4-star analyst with an average return of 4.6% ...
Total Revenue (Q4 2025): $103.9 million, up from $97.9 million in Q4 2024. Total Revenue (Full Year 2025): $370.5 million, a 6% decrease compared to 2024. International Sales (Q4 2025): $48.5 million, ...
InMode ended the year with a strong cash position of $555.3 million and returned $127.4 million to shareholders through share repurchases during 2025. Looking ahead, the company plans to launch two ...
YOKNEAM, Israel (AP) — YOKNEAM, Israel (AP) — InMode Ltd. (INMD) on Tuesday reported net income of $27 million in its fourth quarter. The Yokneam, Israel-based company said it had net income of 42 ...
InMode ( (INMD)) has issued an announcement. On February 2, 2026, InMode issued a statement responding to market speculation surrounding a publicly announced non-binding proposal from Steel Partners ...
The MarketWatch News Department was not involved in the creation of this content. YOKNEAM, Israel, Feb. 3, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results